Last $38.21 USD
Change Today -0.30 / -0.78%
Volume 136.4K
AGIO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Scott Biller Ph.D.

Chief Scientific Officer, Agios Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 3 different organizations across 3 different industries.

See Board Relationships
58$1,015,544
As of Fiscal Year 2013

Background*

Dr. Scott Biller, Ph.D. has been the Chief Scientific Officer of Agios Pharmaceuticals, Inc. since September 2010. Dr. Biller joined Agios from Novartis Pharmaceuticals, where he served as Vice President and Head of Global Discovery Chemistry at the Novartis Institutes for BioMedical Research. He has more than twenty-five years of drug discovery and development experience. At Novartis, Dr. Biller was responsible for the worldwide discovery chemistry functions at NIBR, ...

Read Full Background

Corporate Headquarters*

38 Sidney Street
Cambridge, Massachusetts 02139

United States

Phone: 617-649-8600
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS 1976
Massachusetts Institute of Technology
PhD 1982
California Institute of Technology

Other Affiliations*

Annual Compensation*

Salary$376,000
Total Annual Compensation$376,000

Stock Options*

All Other Compensation$3,099
Exercisable Options203,681
Unexercisable Options54,409
Total Number of Options386,361

Total Compensation*

Total Annual Cash Compensation$537,019
Total Short Term Compensation$376,000
Other Long Term Compensation$3,099
Total Calculated Compensation$1,015,544
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGIO:US $38.21 USD -0.30

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGIOS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.